Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2018, Vol. 12 ›› Issue (02): 65-69. doi: 10.3877/cma.j.issn.1674-0785.2018.02.001

Special Issue:

• Clinical Researches •     Next Articles

Cellular immune function in patients with immune thrombocytopenia

Mingjing Wang1, Yonggang Xu1, Xiaoqing Ding2, Richeng Quan1, Haiyan Chen2, Zhongyang Deng1, Pan Zhao1, Xiaomei Hu1,()   

  1. 1. Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
    2. Department of Hematology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
  • Received:2017-09-01 Online:2018-01-15 Published:2018-01-15
  • Contact: Xiaomei Hu
  • About author:
    Corresponding author: Hu Xiaomei, Email:

Abstract:

Objective

To observe the changes of immune function in patients with immune thrombocytopenia (ITP).

Methods

From May 2016 to February 2017, 40 patients with ITP were enrolled at the Xiyuan Hospital and Dongfang Hospital. Twenty-four healthy persons were also included. The 40 ITP patients were classified into three groups: a chronic group (CG; n=22), a newly diagnostic group (NG; n=9), and a persistent group (PG; n=9). The expression of Th1, Th2, Th17, Treg, and Breg was detected by flow cytometry. Wilcoxon test was used to analyze the difference between the ITP group and the control group (COG), while Kruskal-Wallis test was used for multi-group comparisons.

Results

In comparison with the COG, the expression of Th1 [(16.88±9.02)% vs (8.83±5.3)%, Z=-3.753, P=0.001] and Th1/Th2 ratio [(10.98±9.08)% vs (4.61±3.13)%, Z=-3.596, P=0.001] in patients with ITP were higher, while the levels of Th17 [(1.02±0.37)% vs (1.41±0.38)%, Z=-3.141, P=0.002], Th17/Treg [(1.01±0.37)% vs (0.3±0.05)%, Z=-1.693, P=0.009], and Breg [(1.35±1.37)% vs (2.07±0.86)%, Z=-5.963, P=0.001)] were significantly lower. The expression of Th1 in the CG [(18.75±10.38)%], NG [(16.12±7.72)%], or PG [(13.11±3.83)%] was significantly higher than that in the COG [(8.8±5.3)%, Z=14.83, P=0.002]. Th1/Th2 ratio in the CG [(12.03±10.65)%], NG [(11.63±8.77)%], or PG [(7.77±3.43)%] was significantly higher than that in the COG [(4.61±3.13)%, Z=13.363, P=0.004]. The expression of Th17 in the CG [(1.07±0.33)%], NG [(0.91±0.28)%], or PG [(0.98±0.54)%] was significantly lower than that in the COG [(1.41±0.38)%, Z=10.040, P=0.018]. Th17/Treg ratio in the CG [(0.18±0.01)%], NG [(0.15±0.07)%], or PG [(0.16±0.09)%] was significantly lower than that in the COG [(0.3±0.05)%, Z=3.200, P=0.03]. The expression of Breg in the CG [(1.26±1.54)%], NG [(1.77±1.58)%], or PG [(1.14±0.52)%] was also significantly lower than that in the COG [(2.07±0.86)%, Z=35.731, P=0.001]. There was no difference in the expression of Th2 or Treg between patients with ITP and healthy persons (P>0.05).

Conclusion

Both T and B cell dysfunctions are involved in the pathogenesis of ITP. T cell dysfunction manifests mainly as Th1/Th2 and Th17/Treg imbalance. There is no significant difference in immune cells between different subtypes of ITP patients.

Key words: Immune thrombocytopenia, Immune function, Cellular immunity, Humoral immunity

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd